No Picture
News

BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate Update

SAN JOSE, Calif., Dec. 10, 2019 /PRNewswire/ — BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the fiscal quarter en… […]

No Picture
News

Kodiak Sciences Announces Third Quarter 2019 Financial Results and Recent Business Highlights

PALO ALTO, Calif., Nov. 12, 2019 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today reported business highlights… […]

No Picture
News

Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments

STRO-002 Initial Safety Data from an Ongoing Phase 1 Trial in Ovarian and Endometrial Cancers presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 29, 2019STRO-001 Phase 1 Clinical Trial and Dose Escalation On… […]

No Picture
News

Eiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update

– Successful Pre-NDA and Pre-MAA Meetings for Progeria & Progeroid Laminopathies- Positive Phase 2 LIFT Lambda Combo Data as Late-Breaker at AASLD- First-Ever Phase 3 HDV International D-LIVR Study Enrolling and Dosing- Strong Balance Sheet with $1… […]

No Picture
News

VistaGen Therapeutics Reports Fiscal 2020 Second Quarter Financial Results and Provides Pipeline Overview

SOUTH SAN FRANCISCO, Calif., Nov. 7, 2019 /PRNewswire/ — VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) diseases and disorders with high unmet ne… […]